Accelerating Rare disease Cures (ARC) Program - Kerry Jo Lee, MD, Associate Director for Rare Diseases, US FDA, Center for Drug Evaluation and Research
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at [ Ссылка ]
